Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Thromb Haemost ; 104(4): 724-33, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20664891

ABSTRACT

The role of ethanol metabolism in possible haemostatic cardioprotective effects has not yet been determined. To this end, we investigated the effect of a moderate dose of ethanol (35 g) and its metabolism, on haemostatic variables over 14 hours (h). Eighteen Caucasian males participated in a placebo-controlled, randomised, cross-over study. Blood was collected prior to alcohol consumption, and at 10 time points for 14 h. Blood ethanol peaked at 1 h and was cleared after 8 h following ethanol consumption, significantly increasing plasma acetate (p=0.0028). Ethanol did not influence the coagulation factors significantly. PAI-1act increased (p<0.0001) and tPAact (p=0.047) decreased following alcohol consumption, reaching maximum (0.69 to 22.2 IU/ml) and minimum (0.88 to 0.33 IU/ml) levels at 5 h, respectively. Significantly increased plasma clot lysis times (46.8 to 67.6 minutes) and reduced global fibrinolytic capacity of whole blood, measured as D-dimer production during incubation of blood clots (2.26 to 0.29 µg/ml), were found at 5 h. Except for PAI-1act (borderline significance; p=0.05), there was no significant difference in the fibrinolytic markers between the two groups the following morning. Moderate ethanol consumption resulted in a significant temporary fibrinolysis inhibition. Any protective effects of moderate ethanol consumption on cardiovascular disease do not appear to be due to improvement in fibrinolytic potential within the first 14 h following consumption. The use of global fibrinolytic assays is recommended for determining the true effect of ethanol on fibrinolysis.


Subject(s)
Blood Cells/metabolism , Ethanol/administration & dosage , Fibrin Fibrinogen Degradation Products/metabolism , Fibrinolysis/drug effects , Plasminogen Activator Inhibitor 1/metabolism , Acetates/blood , Adult , Biomarkers/metabolism , Blood Cells/drug effects , Blood Cells/pathology , Blood Coagulation Factors/metabolism , Cells, Cultured , Fibrin Fibrinogen Degradation Products/genetics , Humans , Male , Plasminogen Activator Inhibitor 1/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...